Literature DB >> 10341697

Intramedullary spinal metastasis from carcinoma of the cervix.

R Amin1.   

Abstract

Intramedullary spinal metastases are rare and prior to the availability of MRI were seldom diagnosed antemortem. Lung and breast carcinoma are the most common primary sources. Cervical carcinoma is the least likely source of intramedullary spinal metastases. A case of intramedullary spinal metastases is described in a 29-year-old woman with squamous cell carcinoma of the cervix.

Entities:  

Mesh:

Year:  1999        PMID: 10341697     DOI: 10.1259/bjr.72.853.10341697

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  5 in total

Review 1.  Intramedullary spinal cord metastases in breast cancer: report of four cases and review of the literature.

Authors:  Christos Kosmas; Maria Koumpou; Maria Nikolaou; John Katselis; Georgia Soukouli; Nina Markoutsaki; Vassiliki Kostopoulou; Assimina Gaglia; Nikolaos Mylonakis; Athanassios Karabelis; Dimitrios Pectasides
Journal:  J Neurooncol       Date:  2005-01       Impact factor: 4.130

2.  Intramedullary spinal cord metastasis from colonic carcinoma presenting as Brown-Séquard syndrome: a case report.

Authors:  Mohammed A Kaballo; Darren D Brennan; Mazen El Bassiouni; Stephen J Skehan; Rajnish K Gupta
Journal:  J Med Case Rep       Date:  2011-08-02

Review 3.  Hemangioblastomas and other uncommon intramedullary tumors.

Authors:  D J Miller; I E McCutcheon
Journal:  J Neurooncol       Date:  2000-05       Impact factor: 4.130

4.  Surgical treatment of intramedullary spinal cord metastases of systemic cancer: functional outcome and prognosis.

Authors:  T Gasser; I E Sandalcioglu; B El Hamalawi; J A P van de Nes; D Stolke; H Wiedemayer
Journal:  J Neurooncol       Date:  2005-06       Impact factor: 4.130

5.  Intradural squamous cell carcinoma in the sacrum.

Authors:  Tatsuki Fukushima; Yuichi Kasai; Ko Kato; Kozo Fujisawa; Atsumasa Uchida
Journal:  World J Surg Oncol       Date:  2009-02-11       Impact factor: 2.754

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.